US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Acurx Pharmaceuticals, LLC*

3.50

-0.0900-2.51%

Post-market: 3.43-0.0700-2.00%18:48 EST

Volume:41.38K

Turnover:149.34K

Market Cap:7.28M

PE:-0.34

High:3.72

Open:3.57

Low:3.48

Close:3.59

52wk High:25.00

52wk Low:3.17

Shares:2.08M

Float Shares:1.81M

Volume Ratio:0.91

T/O Rate:2.29%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-10.3664

EPS(LYR):-17.4507

ROE:-291.07%

ROA:-95.64%

PB:2.00

PE(LYR):-0.20

Loading ...

Overview Company News Filings

Acurx Pharmaceuticals, Inc. Regains Full Compliance With Nasdaq Minimum Closing Bid Price and Stockholder Equity Rules

THOMSON REUTERS

Acurx Pharmaceuticals Inc. Unveils Presentation on Advancing New Class of Antibiotics to Phase 3 Trials Targeting Priority Pathogens and Addressing Antimicrobial Resistance

Acurx Pharmaceuticals Reports Q2 2025 Net Loss of $2.2M, EPS of $1.89; R&D Expenses Drop Significantly

Acurx Pharmaceuticals Q2 EPS $(1.89) Up from $(5.21) YoY

Acurx Pharmaceuticals, Inc. Reports Second Quarter Results and Provides Business Update

THOMSON REUTERS

Calendar of U.S. Earnings Expected in the Week Ahead

Acurx Pharmaceuticals Inc. Announces Date for Special Stockholders Meeting

Acurx Pharmaceuticals Announces 1-for-20 Reverse Stock Split Effective August 5, 2025

Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split

THOMSON REUTERS

Acurx Pharmaceuticals Inc - Approves 1-for-20 Reverse Stock Split

THOMSON REUTERS

Acurx Pharmaceuticals Inc. Announces Date for Special Stockholders Meeting

Acurx Pharmaceuticals Inc. Announces Second Quarter 2025 Financial Results Release

Acurx Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 12, 2025 Conference Call and Provide Business Update

THOMSON REUTERS

Acurx Pharmaceuticals Inc. Conducted Annual Meeting of Stockholders

Acurx Pharmaceuticals Announces $2.67 Million Private Placement Through Warrant Exercise

Top Midday Gainers

MT Newswires Live

Acurx Pharmaceuticals Announces Promising Phase 2b Clinical Trial Results for Ibezapolstat in Treating C. difficile Infection, Prepares for Phase 3 Trials

BRIEF-Acurx Pharmaceuticals Announces Presentation Of Results From Leiden University Medical Center Public-Private Partnership For Its DNA pol IIIC Inhibitors

Acurx Pharmaceuticals Announces Advancement of Ibezapolstat to Phase 3 Clinical Trials for C. difficile Infection Treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACXP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACXP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACXP\",,,,,undefined,":{"symbol":"ACXP","market":"US","secType":"STK","nameCN":"Acurx Pharmaceuticals, LLC*","latestPrice":3.5,"timestamp":1766005200000,"preClose":3.59,"halted":0,"volume":41378,"hourTrading":{"tag":"盘后","latestPrice":3.43,"preClose":3.5,"latestTime":"18:48 EST","volume":2046,"amount":7099.81,"timestamp":1766015288996},"delay":0,"floatShares":1808200,"shares":2081300,"eps":-10.366422,"marketStatus":"Closed","change":-0.09,"latestTime":"12-17 16:00:00 EST","open":3.57,"high":3.7228,"low":3.475,"amount":149344.8126668,"amplitude":0.069025,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.366422,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766048400000},"marketStatusCode":5,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":3.59,"preHourTrading":{"tag":"盘前","latestPrice":3.5554,"preClose":3.59,"latestTime":"09:10 EST","volume":184,"amount":654.1936000000001,"timestamp":1765980652540},"postHourTrading":{"tag":"盘后","latestPrice":3.43,"preClose":3.5,"latestTime":"18:48 EST","volume":2046,"amount":7099.81,"timestamp":1766015288996},"volumeRatio":0.913305,"impliedVol":1.1448,"impliedVolPercentile":0.7564},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACXP\",,,,,undefined,":{"symbol":"ACXP","floatShares":1808200,"roa":"-95.64%","roe":"-291.07%","lyrEps":-17.450707,"volumeRatio":0.913305,"shares":2081300,"dividePrice":0,"high":3.7228,"amplitude":0.069025,"preClose":3.59,"low":3.475,"week52Low":3.1713,"pbRate":"2.00","week52High":25,"institutionHeld":0,"latestPrice":3.5,"eps":-10.366422,"divideRate":0,"volume":41378,"delay":0,"ttmEps":-10.366422,"open":3.57,"prevYearClose":16.28,"prevWeekClose":4.07,"prevMonthClose":3.88,"prevQuarterClose":4.29,"fiveDayClose":4.29,"twentyDayClose":4.34,"sixtyDayClose":4.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACXP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"ACXP","fiscalQuarterEnding":"2025/09","expectedEps":-1.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-1.23},{"market":"US","date":"2025-08-12","symbol":"ACXP","fiscalQuarterEnding":"2025/06","expectedEps":2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-08-05","symbol":"ACXP","defaultRemindTime":1754400600000,"type":"split","dateTimestamp":1754366400000,"forFactor":20,"toFactor":1,"ratio":20},{"date":"2025-05-13","symbol":"ACXP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.14,"defaultRemindTime":1747123200000,"name":null,"time":"Pre-Market","dateTimestamp":1747108800000,"actualEps":null},{"market":"US","date":"2025-03-18","symbol":"ACXP","fiscalQuarterEnding":"2024/12","expectedEps":-0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-0.38}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACXP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACXP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1742274000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACXP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACXP","date":"2025-12-16","current":-0.337629,"percent":0.845058,"low":-15.698763,"twenty":-3.874538,"median":-2.691292,"eighty":-0.982298,"high":-0.470005,"avg":-2.954283,"sd":2.25176,"marketCap":7694989},"quantilePoints":[{"date":"2021-06-11","current":-11.938223,"twenty":-11.938223,"median":-11.938223,"eighty":-11.938223,"marketCap":57246954},{"date":"2021-06-15","current":-11.938223,"twenty":-11.938223,"median":-11.938223,"eighty":-11.938223,"marketCap":57246954},{"date":"2021-06-25","current":-15.698763,"twenty":-11.938223,"median":-11.938223,"eighty":-11.938223,"marketCap":75279744},{"date":"2021-07-02","current":-12.09725,"twenty":-12.878918,"median":-11.938223,"eighty":-11.938223,"marketCap":58009530},{"date":"2021-07-09","current":-12.572868,"twenty":-12.738301,"median":-11.938223,"eighty":-11.938223,"marketCap":60290246},{"date":"2021-07-16","current":-12.469473,"twenty":-12.639041,"median":-12.076571,"eighty":-11.938223,"marketCap":59794438},{"date":"2021-07-23","current":-11.518236,"twenty":-12.560461,"median":-12.014533,"eighty":-11.866925,"marketCap":55233005},{"date":"2021-07-30","current":-11.745706,"twenty":-12.502559,"median":-11.938223,"eighty":-11.580273,"marketCap":56323783},{"date":"2021-08-06","current":-10.050023,"twenty":-12.458729,"median":-11.938223,"eighty":-11.427248,"marketCap":48192532},{"date":"2021-08-13","current":-6.159321,"twenty":-12.399613,"median":-11.893662,"eighty":-10.608357,"marketCap":48572198},{"date":"2021-08-20","current":-5.607549,"twenty":-12.287497,"median":-11.828422,"eighty":-10.06243,"marketCap":44220938},{"date":"2021-08-27","current":-6.172153,"twenty":-12.088978,"median":-11.528575,"eighty":-7.064488,"marketCap":48673390},{"date":"2021-09-03","current":-7.416849,"twenty":-12.051755,"median":-11.476878,"eighty":-6.405694,"marketCap":58489022},{"date":"2021-09-10","current":-6.41596,"twenty":-12.035212,"median":-10.897864,"eighty":-6.364632,"marketCap":50596040},{"date":"2021-09-17","current":-5.877019,"twenty":-12.014533,"median":-10.608357,"eighty":-6.364632,"marketCap":46345972},{"date":"2021-09-24","current":-5.626797,"twenty":-11.938223,"median":-10.215455,"eighty":-6.172153,"marketCap":44372727},{"date":"2021-10-01","current":-6.68543,"twenty":-11.938223,"median":-9.998325,"eighty":-6.159321,"marketCap":52721073},{"date":"2021-10-08","current":-5.248255,"twenty":-11.938223,"median":-9.863911,"eighty":-5.992506,"marketCap":41387560},{"date":"2021-10-15","current":-6.300472,"twenty":-11.938223,"median":-7.333442,"eighty":-5.979674,"marketCap":49685311},{"date":"2021-10-22","current":-6.184985,"twenty":-11.938223,"median":-6.865077,"eighty":-5.979674,"marketCap":48774582},{"date":"2021-10-29","current":-6.41596,"twenty":-11.938223,"median":-6.794501,"eighty":-5.992506,"marketCap":50596040},{"date":"2021-11-05","current":-6.852245,"twenty":-11.938223,"median":-6.865077,"eighty":-6.031002,"marketCap":54036570},{"date":"2021-11-12","current":-4.527743,"twenty":-11.849101,"median":-6.858661,"eighty":-6.031002,"marketCap":50772486},{"date":"2021-11-19","current":-4.427531,"twenty":-11.828422,"median":-6.736758,"eighty":-5.966842,"marketCap":49648749},{"date":"2021-11-26","current":-4.454861,"twenty":-11.828422,"median":-6.68543,"eighty":-5.861621,"marketCap":49955222},{"date":"2021-12-03","current":-3.780711,"twenty":-11.762249,"median":-6.614854,"eighty":-5.699938,"marketCap":42395536},{"date":"2021-12-10","current":-3.835372,"twenty":-11.580273,"median":-6.557111,"eighty":-5.569053,"marketCap":43008484},{"date":"2021-12-17","current":-4.035795,"twenty":-11.522372,"median":-6.505783,"eighty":-5.166131,"marketCap":45255958},{"date":"2021-12-23","current":-4.32732,"twenty":-11.493421,"median":-6.428792,"eighty":-4.527743,"marketCap":48525012},{"date":"2021-12-31","current":-3.936859,"twenty":-11.476878,"median":-6.41596,"eighty":-4.409311,"marketCap":44146523},{"date":"2022-01-07","current":-4.017574,"twenty":-11.439656,"median":-6.358216,"eighty":-4.32732,"marketCap":45051642},{"date":"2022-01-14","current":-4.172447,"twenty":-11.104655,"median":-6.313304,"eighty":-4.289057,"marketCap":46788327},{"date":"2022-01-21","current":-3.316093,"twenty":-10.839963,"median":-6.223481,"eighty":-4.21982,"marketCap":37185482},{"date":"2022-01-28","current":-3.534737,"twenty":-10.695209,"median":-6.172153,"eighty":-4.137828,"marketCap":39637272},{"date":"2022-02-04","current":-3.589398,"twenty":-10.608357,"median":-6.159321,"eighty":-4.074057,"marketCap":40250220},{"date":"2022-02-11","current":-3.71694,"twenty":-10.550456,"median":-6.063082,"eighty":-4.024862,"marketCap":41680431},{"date":"2022-02-18","current":-3.73516,"twenty":-10.364344,"median":-5.979674,"eighty":-3.984778,"marketCap":41884747},{"date":"2022-02-25","current":-3.252322,"twenty":-10.194776,"median":-5.966842,"eighty":-3.953804,"marketCap":36470377},{"date":"2022-03-04","current":-3.252322,"twenty":-10.099653,"median":-5.896267,"eighty":-3.859058,"marketCap":36470377},{"date":"2022-03-11","current":-3.644059,"twenty":-10.029344,"median":-5.787196,"eighty":-3.791643,"marketCap":40863168},{"date":"2022-03-18","current":-2.922007,"twenty":-9.942491,"median":-5.68454,"eighty":-3.755202,"marketCap":37248855},{"date":"2022-03-25","current":-2.838922,"twenty":-9.913541,"median":-5.607549,"eighty":-3.720584,"marketCap":36189718},{"date":"2022-04-01","current":-2.737374,"twenty":-9.379631,"median":-5.44715,"eighty":-3.682321,"marketCap":34895218},{"date":"2022-04-08","current":-2.881869,"twenty":-7.43738,"median":-5.248255,"eighty":-3.645881,"marketCap":36737195},{"date":"2022-04-14","current":-3.210996,"twenty":-7.416849,"median":-4.609734,"eighty":-3.634948,"marketCap":40932808},{"date":"2022-04-22","current":-3.210996,"twenty":-7.250034,"median":-4.504968,"eighty":-3.534737,"marketCap":40932808},{"date":"2022-04-29","current":-3.003032,"twenty":-7.237203,"median":-4.427531,"eighty":-3.388974,"marketCap":38281743},{"date":"2022-05-06","current":-3.123797,"twenty":-7.121715,"median":-4.35465,"eighty":-3.315273,"marketCap":39821223},{"date":"2022-05-13","current":-1.994712,"twenty":-7.044724,"median":-4.32732,"eighty":-3.252322,"marketCap":27813277},{"date":"2022-05-20","current":-1.943188,"twenty":-7.01906,"median":-4.318209,"eighty":-3.210996,"marketCap":27094853},{"date":"2022-05-27","current":-1.923388,"twenty":-6.993396,"median":-4.236218,"eighty":-3.146776,"marketCap":26818773},{"date":"2022-06-03","current":-1.880623,"twenty":-6.942068,"median":-4.208888,"eighty":-3.079156,"marketCap":26222481},{"date":"2022-06-10","current":-2.774931,"twenty":-6.918971,"median":-4.158782,"eighty":-3.024918,"marketCap":38692271},{"date":"2022-06-17","current":-2.679244,"twenty":-6.906139,"median":-4.117786,"eighty":-2.999671,"marketCap":37358055},{"date":"2022-06-24","current":-2.716047,"twenty":-6.880475,"median":-4.090456,"eighty":-2.939922,"marketCap":37871215},{"date":"2022-07-01","current":-2.76021,"twenty":-6.857378,"median":-4.044905,"eighty":-2.90143,"marketCap":38487007},{"date":"2022-07-08","current":-2.760137,"twenty":-6.852245,"median":-4.026684,"eighty":-2.848154,"marketCap":38485981},{"date":"2022-07-15","current":-2.668203,"twenty":-6.80605,"median":-4.008464,"eighty":-2.820986,"marketCap":37204107},{"date":"2022-07-22","current":-2.657162,"twenty":-6.72136,"median":-3.972024,"eighty":-2.802901,"marketCap":37050159},{"date":"2022-07-29","current":-2.635081,"twenty":-6.693129,"median":-3.953804,"eighty":-2.779424,"marketCap":36742263},{"date":"2022-08-05","current":-2.88534,"twenty":-6.68543,"median":-3.921918,"eighty":-2.779424,"marketCap":40231751},{"date":"2022-08-12","current":-3.956018,"twenty":-6.664899,"median":-3.844482,"eighty":-2.782292,"marketCap":49687496},{"date":"2022-08-19","current":-3.519492,"twenty":-6.618704,"median":-3.839927,"eighty":-2.785236,"marketCap":44204738},{"date":"2022-08-26","current":-3.110248,"twenty":-6.585341,"median":-3.798931,"eighty":-2.789652,"marketCap":39064652},{"date":"2022-09-02","current":-3.073871,"twenty":-6.56481,"median":-3.780666,"eighty":-2.792596,"marketCap":38607755},{"date":"2022-09-09","current":-3.965112,"twenty":-6.551978,"median":-3.772829,"eighty":-2.798485,"marketCap":49801720},{"date":"2022-09-16","current":-3.542438,"twenty":-6.531447,"median":-3.78062,"eighty":-2.805846,"marketCap":44492944},{"date":"2022-09-23","current":-2.787945,"twenty":-6.521181,"median":-3.757935,"eighty":-2.805846,"marketCap":35016525},{"date":"2022-09-30","current":-2.760341,"twenty":-6.47242,"median":-3.73516,"eighty":-2.805846,"marketCap":34669827},{"date":"2022-10-07","current":-3.128387,"twenty":-6.436491,"median":-3.71694,"eighty":-2.811734,"marketCap":39292470},{"date":"2022-10-14","current":-2.714336,"twenty":-6.41596,"median":-3.689609,"eighty":-2.811734,"marketCap":34091996},{"date":"2022-10-21","current":-2.806347,"twenty":-6.41596,"median":-3.672742,"eighty":-2.791124,"marketCap":35247657},{"date":"2022-10-28","current":-3.027174,"twenty":-6.413394,"median":-3.653169,"eighty":-2.791124,"marketCap":38021243},{"date":"2022-11-04","current":-2.723537,"twenty":-6.395429,"median":-3.644059,"eighty":-2.783423,"marketCap":34207562},{"date":"2022-11-11","current":-2.94384,"twenty":-6.362066,"median":-3.619529,"eighty":-2.778468,"marketCap":33734492},{"date":"2022-11-18","current":-3.196747,"twenty":-6.346667,"median":-3.595377,"eighty":-2.782292,"marketCap":36632644},{"date":"2022-11-25","current":-2.953956,"twenty":-6.326136,"median":-3.588921,"eighty":-2.782292,"marketCap":33850418},{"date":"2022-12-02","current":-3.338375,"twenty":-6.313304,"median":-3.534737,"eighty":-2.787945,"marketCap":38255609},{"date":"2022-12-09","current":-3.743026,"twenty":-6.300472,"median":-3.538588,"eighty":-2.789652,"marketCap":42892653},{"date":"2022-12-16","current":-3.874538,"twenty":-6.223481,"median":-3.589398,"eighty":-2.789652,"marketCap":44399692},{"date":"2022-12-23","current":-3.975701,"twenty":-6.184985,"median":-3.603063,"eighty":-2.797013,"marketCap":45558953},{"date":"2022-12-30","current":-4.026282,"twenty":-6.174719,"median":-3.62058,"eighty":-2.802902,"marketCap":46138583},{"date":"2023-01-06","current":-4.501748,"twenty":-6.172153,"median":-3.638406,"eighty":-2.805558,"marketCap":51587110},{"date":"2023-01-13","current":-4.299422,"twenty":-6.164454,"median":-3.644059,"eighty":-2.809579,"marketCap":49268588},{"date":"2023-01-20","current":-4.258957,"twenty":-6.159321,"median":-3.653169,"eighty":-2.811734,"marketCap":48804883},{"date":"2023-01-27","current":-3.884654,"twenty":-6.149055,"median":-3.672742,"eighty":-2.8141,"marketCap":44515618},{"date":"2023-02-03","current":-3.540701,"twenty":-6.118259,"median":-3.662279,"eighty":-2.817733,"marketCap":40574131},{"date":"2023-02-10","current":-3.540701,"twenty":-6.069498,"median":-3.644059,"eighty":-2.819825,"marketCap":40574131},{"date":"2023-02-17","current":-3.70246,"twenty":-6.015604,"median":-3.644059,"eighty":-2.823936,"marketCap":42427789},{"date":"2023-02-24","current":-3.287793,"twenty":-5.98994,"median":-3.641863,"eighty":-2.825677,"marketCap":37675979},{"date":"2023-03-03","current":-3.641863,"twenty":-5.979674,"median":-3.638406,"eighty":-2.827332,"marketCap":41733392},{"date":"2023-03-10","current":-3.469887,"twenty":-5.977108,"median":-3.621631,"eighty":-2.83395,"marketCap":39762648},{"date":"2023-03-17","current":-3.021341,"twenty":-5.959143,"median":-3.604508,"eighty":-2.834944,"marketCap":36536396},{"date":"2023-03-24","current":-3.406225,"twenty":-5.925781,"median":-3.592246,"eighty":-2.839484,"marketCap":41190714},{"date":"2023-03-31","current":-3.329248,"twenty":-5.907816,"median":-3.59034,"eighty":-2.843856,"marketCap":40259850},{"date":"2023-04-06","current":-3.396603,"twenty":-5.877019,"median":-3.579746,"eighty":-2.852353,"marketCap":41074356},{"date":"2023-04-14","current":-2.751922,"twenty":-5.800028,"median":-3.550817,"eighty":-2.852353,"marketCap":33278373},{"date":"2023-04-21","current":-2.97323,"twenty":-5.787196,"median":-3.550817,"eighty":-2.848143,"marketCap":35954606},{"date":"2023-04-28","current":-2.866607,"twenty":-5.735868,"median":-3.540701,"eighty":-2.852353,"marketCap":34665231},{"date":"2023-05-05","current":-2.827999,"twenty":-5.710204,"median":-3.534737,"eighty":-2.841732,"marketCap":34198359},{"date":"2023-05-12","current":-3.19477,"twenty":-5.669142,"median":-3.525038,"eighty":-2.846189,"marketCap":38633641},{"date":"2023-05-19","current":-2.850337,"twenty":-5.633213,"median":-3.510352,"eighty":-2.847975,"marketCap":35132102},{"date":"2023-05-26","current":-2.937567,"twenty":-5.611399,"median":-3.474945,"eighty":-2.849898,"marketCap":36207255},{"date":"2023-06-02","current":-2.937567,"twenty":-5.59985,"median":-3.447184,"eighty":-2.851547,"marketCap":36207255},{"date":"2023-06-09","current":-2.808114,"twenty":-5.517726,"median":-3.439538,"eighty":-2.851547,"marketCap":34611681},{"date":"2023-06-16","current":-2.738409,"twenty":-5.4433,"median":-3.429421,"eighty":-2.847807,"marketCap":33752526},{"date":"2023-06-23","current":-2.569126,"twenty":-5.402238,"median":-3.402649,"eighty":-2.838681,"marketCap":31666006},{"date":"2023-06-30","current":-2.68862,"twenty":-5.340645,"median":-3.397344,"eighty":-2.829189,"marketCap":33138844},{"date":"2023-07-07","current":-2.540461,"twenty":-5.248255,"median":-3.388974,"eighty":-2.822775,"marketCap":31312689},{"date":"2023-07-14","current":-2.40399,"twenty":-4.837634,"median":-3.364889,"eighty":-2.811734,"marketCap":29630603},{"date":"2023-07-21","current":-2.361999,"twenty":-4.609734,"median":-3.350513,"eighty":-2.798157,"marketCap":29113038},{"date":"2023-07-28","current":-1.847608,"twenty":-4.542213,"median":-3.33875,"eighty":-2.787945,"marketCap":22772865},{"date":"2023-08-04","current":-2.21503,"twenty":-4.527743,"median":-3.338375,"eighty":-2.777512,"marketCap":27301560},{"date":"2023-08-11","current":-1.900097,"twenty":-4.527743,"median":-3.329248,"eighty":-2.760341,"marketCap":23419821},{"date":"2023-08-18","current":-1.869135,"twenty":-4.501748,"median":-3.318884,"eighty":-2.76021,"marketCap":24579691},{"date":"2023-08-25","current":-2.017479,"twenty":-4.482192,"median":-3.315273,"eighty":-2.741939,"marketCap":26530461},{"date":"2023-09-01","current":-1.908693,"twenty":-4.454861,"median":-3.304204,"eighty":-2.73148,"marketCap":25099897},{"date":"2023-09-08","current":-1.75046,"twenty":-4.432997,"median":-3.297891,"eighty":-2.723392,"marketCap":23019076},{"date":"2023-09-15","current":-1.710901,"twenty":-4.39109,"median":-3.28304,"eighty":-2.713206,"marketCap":22498871},{"date":"2023-09-22","current":-1.582336,"twenty":-4.374692,"median":-3.266474,"eighty":-2.696583,"marketCap":20808204},{"date":"2023-09-29","current":-1.463661,"twenty":-4.343718,"median":-3.252322,"eighty":-2.679128,"marketCap":19247589},{"date":"2023-10-06","current":-1.542778,"twenty":-4.329142,"median":-3.235119,"eighty":-2.671147,"marketCap":20287999},{"date":"2023-10-13","current":-4.034958,"twenty":-4.32732,"median":-3.237569,"eighty":-2.671147,"marketCap":53060922},{"date":"2023-10-20","current":-4.964581,"twenty":-4.374692,"median":-3.256877,"eighty":-2.671883,"marketCap":65285742},{"date":"2023-10-27","current":-4.667893,"twenty":-4.397094,"median":-3.266474,"eighty":-2.673013,"marketCap":61384204},{"date":"2023-11-03","current":-3.758049,"twenty":-4.476726,"median":-3.28304,"eighty":-2.677757,"marketCap":49419486},{"date":"2023-11-10","current":-3.708601,"twenty":-4.449395,"median":-3.283194,"eighty":-2.678778,"marketCap":48769230},{"date":"2023-11-17","current":-3.917109,"twenty":-4.422199,"median":-3.297873,"eighty":-2.680716,"marketCap":49840076},{"date":"2023-11-24","current":-4.187628,"twenty":-4.400873,"median":-3.300382,"eighty":-2.686605,"marketCap":53282070},{"date":"2023-12-01","current":-3.808902,"twenty":-4.38198,"median":-3.312639,"eighty":-2.68862,"marketCap":48463279},{"date":"2023-12-08","current":-4.696202,"twenty":-4.38198,"median":-3.318142,"eighty":-2.693965,"marketCap":59753020},{"date":"2023-12-15","current":-3.63577,"twenty":-4.37287,"median":-3.328111,"eighty":-2.697237,"marketCap":46260402},{"date":"2023-12-22","current":-3.884647,"twenty":-4.343718,"median":-3.333812,"eighty":-2.703555,"marketCap":49427037},{"date":"2023-12-29","current":-4.295835,"twenty":-4.333177,"median":-3.338375,"eighty":-2.706495,"marketCap":54658868},{"date":"2024-01-05","current":-4.285014,"twenty":-4.33643,"median":-3.338563,"eighty":-2.708536,"marketCap":54521188},{"date":"2024-01-12","current":-5.204777,"twenty":-4.400873,"median":-3.348492,"eighty":-2.708686,"marketCap":66223969},{"date":"2024-01-19","current":-4.328297,"twenty":-4.440176,"median":-3.358415,"eighty":-2.713206,"marketCap":55071908},{"date":"2024-01-26","current":-4.317476,"twenty":-4.429326,"median":-3.377159,"eighty":-2.715705,"marketCap":54934228},{"date":"2024-02-02","current":-3.527562,"twenty":-4.406205,"median":-3.396603,"eighty":-2.721877,"marketCap":44883605},{"date":"2024-02-09","current":-3.321968,"twenty":-4.385759,"median":-3.397158,"eighty":-2.723334,"marketCap":42267689},{"date":"2024-02-16","current":-3.300327,"twenty":-4.374692,"median":-3.388974,"eighty":-2.723392,"marketCap":41992329},{"date":"2024-02-23","current":-3.386893,"twenty":-4.359111,"median":-3.386893,"eighty":-2.723485,"marketCap":43093768},{"date":"2024-03-01","current":-3.105553,"twenty":-4.341834,"median":-3.386893,"eighty":-2.727023,"marketCap":39514093},{"date":"2024-03-08","current":-3.213761,"twenty":-4.33155,"median":-3.364889,"eighty":-2.730627,"marketCap":40890891},{"date":"2024-03-15","current":-2.932421,"twenty":-4.328297,"median":-3.350513,"eighty":-2.735016,"marketCap":37311217},{"date":"2024-03-22","current":-2.226653,"twenty":-4.328297,"median":-3.33875,"eighty":-2.723485,"marketCap":32459630},{"date":"2024-03-28","current":-2.518496,"twenty":-4.327906,"median":-3.338375,"eighty":-2.718962,"marketCap":36714047},{"date":"2024-04-05","current":-2.118563,"twenty":-4.32732,"median":-3.329248,"eighty":-2.706495,"marketCap":30883919},{"date":"2024-04-12","current":-2.021282,"twenty":-4.323676,"median":-3.321968,"eighty":-2.687411,"marketCap":29465780},{"date":"2024-04-19","current":-2.302316,"twenty":-4.318209,"median":-3.318884,"eighty":-2.674142,"marketCap":33562627},{"date":"2024-04-26","current":-2.183417,"twenty":-4.318209,"median":-3.315273,"eighty":-2.664523,"marketCap":31829346},{"date":"2024-05-03","current":-2.301105,"twenty":-4.317916,"median":-3.304204,"eighty":-2.652746,"marketCap":33544976},{"date":"2024-05-10","current":-2.192562,"twenty":-4.316324,"median":-3.29791,"eighty":-2.63511,"marketCap":31962666},{"date":"2024-05-17","current":-2.129106,"twenty":-4.308527,"median":-3.285571,"eighty":-2.616729,"marketCap":34177900},{"date":"2024-05-24","current":-2.57267,"twenty":-4.299422,"median":-3.281137,"eighty":-2.577025,"marketCap":41298296},{"date":"2024-05-31","current":-2.477227,"twenty":-4.298705,"median":-3.261432,"eighty":-2.56885,"marketCap":39766186},{"date":"2024-06-07","current":-2.368663,"twenty":-4.295086,"median":-3.249273,"eighty":-2.539607,"marketCap":38023444},{"date":"2024-06-14","current":-2.398272,"twenty":-4.291572,"median":-3.237569,"eighty":-2.530033,"marketCap":38498737},{"date":"2024-06-21","current":-2.299577,"twenty":-4.289508,"median":-3.235402,"eighty":-2.519465,"marketCap":36914427},{"date":"2024-06-28","current":-2.220622,"twenty":-4.285014,"median":-3.234651,"eighty":-2.502591,"marketCap":35646979},{"date":"2024-07-05","current":-2.033103,"twenty":-4.280355,"median":-3.233027,"eighty":-2.482891,"marketCap":32636790},{"date":"2024-07-12","current":-2.279839,"twenty":-4.271096,"median":-3.223405,"eighty":-2.467358,"marketCap":36597565},{"date":"2024-07-19","current":-2.398272,"twenty":-4.264513,"median":-3.212378,"eighty":-2.463479,"marketCap":38498737},{"date":"2024-07-26","current":-2.25023,"twenty":-4.25984,"median":-3.210996,"eighty":-2.445645,"marketCap":36122272},{"date":"2024-08-02","current":-2.08245,"twenty":-4.250864,"median":-3.208522,"eighty":-2.402846,"marketCap":33428945},{"date":"2024-08-09","current":-1.825588,"twenty":-4.246031,"median":-3.202969,"eighty":-2.384084,"marketCap":30540786},{"date":"2024-08-16","current":-1.951826,"twenty":-4.23804,"median":-3.197661,"eighty":-2.361358,"marketCap":32652648},{"date":"2024-08-23","current":-2.204301,"twenty":-4.236218,"median":-3.19477,"eighty":-2.345346,"marketCap":36876374},{"date":"2024-08-30","current":-2.136326,"twenty":-4.223316,"median":-3.188517,"eighty":-2.302074,"marketCap":35739217},{"date":"2024-09-06","current":-1.922694,"twenty":-4.219131,"median":-3.172148,"eighty":-2.286104,"marketCap":32165296},{"date":"2024-09-13","current":-1.980957,"twenty":-4.218492,"median":-3.165041,"eighty":-2.275891,"marketCap":33140001},{"date":"2024-09-20","current":-1.951826,"twenty":-4.21273,"median":-3.15797,"eighty":-2.265537,"marketCap":32652648},{"date":"2024-09-27","current":-1.86443,"twenty":-4.202511,"median":-3.146776,"eighty":-2.257421,"marketCap":31190590},{"date":"2024-10-04","current":-2.087774,"twenty":-4.19188,"median":-3.130117,"eighty":-2.249446,"marketCap":34926962},{"date":"2024-10-11","current":-2.010089,"twenty":-4.187628,"median":-3.128387,"eighty":-2.234788,"marketCap":33627354},{"date":"2024-10-18","current":-1.951826,"twenty":-4.187628,"median":-3.113033,"eighty":-2.220622,"marketCap":32652648},{"date":"2024-10-25","current":-1.786746,"twenty":-4.178519,"median":-3.10794,"eighty":-2.213319,"marketCap":29890982},{"date":"2024-11-01","current":-1.806167,"twenty":-4.166981,"median":-3.100143,"eighty":-2.203947,"marketCap":30215884},{"date":"2024-11-08","current":-1.806167,"twenty":-4.157871,"median":-3.088695,"eighty":-2.19356,"marketCap":30215884},{"date":"2024-11-15","current":-1.767787,"twenty":-4.150298,"median":-3.081142,"eighty":-2.181144,"marketCap":29055182},{"date":"2024-11-22","current":-1.387508,"twenty":-4.135209,"median":-3.07318,"eighty":-2.149641,"marketCap":22804939},{"date":"2024-11-29","current":-1.284729,"twenty":-4.125219,"median":-3.065235,"eighty":-2.140727,"marketCap":21115685},{"date":"2024-12-06","current":-0.770838,"twenty":-4.120736,"median":-3.05063,"eighty":-2.136326,"marketCap":12669411},{"date":"2024-12-13","current":-0.878858,"twenty":-4.111282,"median":-3.042419,"eighty":-2.129883,"marketCap":14444817},{"date":"2024-12-20","current":-0.847921,"twenty":-4.10134,"median":-3.035027,"eighty":-2.112058,"marketCap":13936352},{"date":"2024-12-27","current":-0.918838,"twenty":-4.100763,"median":-3.029808,"eighty":-2.097994,"marketCap":15101937},{"date":"2025-01-03","current":-0.914624,"twenty":-4.099566,"median":-3.026769,"eighty":-2.087774,"marketCap":15032678},{"date":"2025-01-10","current":-0.830655,"twenty":-4.092278,"median":-3.023853,"eighty":-2.081672,"marketCap":13652557},{"date":"2025-01-17","current":-0.907533,"twenty":-4.090284,"median":-3.019134,"eighty":-2.067585,"marketCap":14916119},{"date":"2025-01-24","current":-0.895816,"twenty":-4.090241,"median":-3.010309,"eighty":-2.058642,"marketCap":14723544},{"date":"2025-01-31","current":-0.750899,"twenty":-4.090241,"median":-2.997753,"eighty":-2.043977,"marketCap":12341695},{"date":"2025-02-07","current":-0.795813,"twenty":-4.088284,"median":-2.986227,"eighty":-2.027397,"marketCap":13079899},{"date":"2025-02-14","current":-0.762615,"twenty":-4.072667,"median":-2.973442,"eighty":-2.016716,"marketCap":12534270},{"date":"2025-02-21","current":-0.804343,"twenty":-4.056659,"median":-2.970335,"eighty":-2.010243,"marketCap":13220108},{"date":"2025-02-28","current":-0.729212,"twenty":-4.04696,"median":-2.964072,"eighty":-1.994631,"marketCap":11985262},{"date":"2025-03-07","current":-0.470005,"twenty":-4.046781,"median":-2.953761,"eighty":-1.988678,"marketCap":7724962},{"date":"2025-03-14","current":-0.534112,"twenty":-4.045871,"median":-2.953473,"eighty":-1.982077,"marketCap":8778614},{"date":"2025-03-21","current":-0.661755,"twenty":-4.044905,"median":-2.944364,"eighty":-1.980421,"marketCap":9332799},{"date":"2025-03-28","current":-0.638311,"twenty":-4.041261,"median":-2.937567,"eighty":-1.964134,"marketCap":9002161},{"date":"2025-04-04","current":-0.500145,"twenty":-4.03546,"median":-2.933581,"eighty":-1.951826,"marketCap":7053603},{"date":"2025-04-11","current":-0.553755,"twenty":-4.032484,"median":-2.92512,"eighty":-1.947591,"marketCap":7809661},{"date":"2025-04-17","current":-0.58267,"twenty":-4.028274,"median":-2.922007,"eighty":-1.938558,"marketCap":8217448},{"date":"2025-04-25","current":-0.632371,"twenty":-4.026282,"median":-2.909973,"eighty":-1.922833,"marketCap":8918399},{"date":"2025-05-02","current":-0.645031,"twenty":-4.026089,"median":-2.905875,"eighty":-1.915453,"marketCap":9096944},{"date":"2025-05-09","current":-0.562664,"twenty":-4.023768,"median":-2.898358,"eighty":-1.909551,"marketCap":7935303},{"date":"2025-05-16","current":-0.71839,"twenty":-4.016958,"median":-2.893258,"eighty":-1.899063,"marketCap":8530451},{"date":"2025-05-23","current":-0.73918,"twenty":-4.01329,"median":-2.887777,"eighty":-1.872577,"marketCap":8777327},{"date":"2025-05-30","current":-0.717833,"twenty":-4.008464,"median":-2.885625,"eighty":-1.86443,"marketCap":8523839},{"date":"2025-06-06","current":-0.687081,"twenty":-4.008464,"median":-2.879956,"eighty":-1.85472,"marketCap":8158684},{"date":"2025-06-13","current":-0.652772,"twenty":-4.00605,"median":-2.871746,"eighty":-1.84598,"marketCap":7751278},{"date":"2025-06-20","current":-1.423798,"twenty":-4.00415,"median":-2.862255,"eighty":-1.845009,"marketCap":16906756},{"date":"2025-06-27","current":-0.947419,"twenty":-4.003675,"median":-2.857787,"eighty":-1.834155,"marketCap":11250037},{"date":"2025-07-03","current":-0.953154,"twenty":-3.997446,"median":-2.850337,"eighty":-1.826753,"marketCap":11318134},{"date":"2025-07-11","current":-0.986771,"twenty":-3.99303,"median":-2.844518,"eighty":-1.817857,"marketCap":11717321},{"date":"2025-07-18","current":-1.111951,"twenty":-3.991288,"median":-2.838521,"eighty":-1.811994,"marketCap":13203761},{"date":"2025-07-25","current":-1.094616,"twenty":-3.985317,"median":-2.830974,"eighty":-1.796456,"marketCap":12997912},{"date":"2025-08-01","current":-0.807341,"twenty":-3.981494,"median":-2.825677,"eighty":-1.786746,"marketCap":9586695},{"date":"2025-08-08","current":-0.602367,"twenty":-3.977874,"median":-2.817754,"eighty":-1.767581,"marketCap":7152755},{"date":"2025-08-15","current":-0.770288,"twenty":-3.969348,"median":-2.811734,"eighty":-1.75046,"marketCap":7702006},{"date":"2025-08-22","current":-0.721155,"twenty":-3.963793,"median":-2.80536,"eighty":-1.724968,"marketCap":7210726},{"date":"2025-08-29","current":-0.756024,"twenty":-3.958776,"median":-2.798157,"eighty":-1.697056,"marketCap":7559376},{"date":"2025-09-05","current":-0.611793,"twenty":-3.955132,"median":-2.789652,"eighty":-1.646476,"marketCap":6117231},{"date":"2025-09-12","current":-0.676776,"twenty":-3.953804,"median":-2.785119,"eighty":-1.558601,"marketCap":6766989},{"date":"2025-09-19","current":-0.687871,"twenty":-3.950423,"median":-2.778241,"eighty":-1.48344,"marketCap":6877923},{"date":"2025-09-26","current":-0.613613,"twenty":-3.941955,"median":-2.772237,"eighty":-1.425726,"marketCap":6135432},{"date":"2025-10-03","current":-0.696039,"twenty":-3.932705,"median":-2.760341,"eighty":-1.390278,"marketCap":6959595},{"date":"2025-10-10","current":-1.135642,"twenty":-3.925931,"median":-2.760275,"eighty":-1.273413,"marketCap":11355128},{"date":"2025-10-17","current":-1.07306,"twenty":-3.922017,"median":-2.760137,"eighty":-1.189811,"marketCap":10729375},{"date":"2025-10-24","current":-0.992161,"twenty":-3.917261,"median":-2.747749,"eighty":-1.154085,"marketCap":9920475},{"date":"2025-10-31","current":-0.778464,"twenty":-3.917109,"median":-2.738409,"eighty":-1.120028,"marketCap":7783757},{"date":"2025-11-07","current":-0.763201,"twenty":-3.908453,"median":-2.734427,"eighty":-1.099569,"marketCap":7631135},{"date":"2025-11-14","current":-0.723514,"twenty":-3.895189,"median":-2.723537,"eighty":-1.078885,"marketCap":7234315},{"date":"2025-11-21","current":-0.889174,"twenty":-3.890724,"median":-2.723334,"eighty":-1.044867,"marketCap":8153769},{"date":"2025-11-28","current":-0.882351,"twenty":-3.884653,"median":-2.715191,"eighty":-1.007961,"marketCap":8091208},{"date":"2025-12-05","current":-0.791387,"twenty":-3.882625,"median":-2.708536,"eighty":-0.992466,"marketCap":7257063},{"date":"2025-12-12","current":-0.934656,"twenty":-3.874538,"median":-2.695601,"eighty":-0.987318,"marketCap":8570841},{"date":"2025-12-16","current":-0.839143,"twenty":-3.874538,"median":-2.691292,"eighty":-0.982298,"marketCap":7694989}],"updateTime":1766028792197},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACXP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2564178367","title":"Acurx Pharmaceuticals, Inc. Regains Full Compliance With Nasdaq Minimum Closing Bid Price and Stockholder Equity Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2564178367","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564178367?lang=en_us&edition=fundamental","pubTime":"2025-09-03 19:01","pubTimestamp":1756897262,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nTUA5FB6SP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACXP","BK4539","BK4563"],"gpt_icon":0},{"id":"2562036014","title":"Acurx Pharmaceuticals Inc. Unveils Presentation on Advancing New Class of Antibiotics to Phase 3 Trials Targeting Priority Pathogens and Addressing Antimicrobial Resistance","url":"https://stock-news.laohu8.com/highlight/detail?id=2562036014","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562036014?lang=en_us&edition=fundamental","pubTime":"2025-08-28 19:23","pubTimestamp":1756380207,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc. Unveils Presentation on Advancing New Class of Antibiotics to Phase 3 Trials Targeting Priority Pathogens and Addressing Antimicrobial Resistance. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief on August 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL7Jdg8X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4539","ACXP","BK4139"],"gpt_icon":0},{"id":"2558649125","title":"Acurx Pharmaceuticals Reports Q2 2025 Net Loss of $2.2M, EPS of $1.89; R&D Expenses Drop Significantly","url":"https://stock-news.laohu8.com/highlight/detail?id=2558649125","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558649125?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:05","pubTimestamp":1754996727,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc. , a late-stage biopharmaceutical company, reported its financial results for the second quarter ending June 30, 2025. The company posted a net loss of $2.2 million for the three months ended June 30, 2025, compared to a net loss of $4.1 million for the same period in 2024. For the six months ended June 30, 2025, the net loss was $4.4 million, a decrease from the net loss of $8.5 million reported for the same period in 2024. The company successfully executed a warrant inducement transaction, resulting in gross proceeds of approximately $2.7 million, with net proceeds of $2.5 million after deducting fees and transaction expenses. Acurx Pharmaceuticals continues its multi-step approach to raising capital through various financings, warrant inducements, and public-private partnership opportunities. In June, significant progress was made with the publication of Phase 2b clinical trial data for ibezapolstat in C. Difficile infection in the Lancet Microbe, a leading","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDLc9MGZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP"],"gpt_icon":0},{"id":"2558499606","title":"Acurx Pharmaceuticals Q2 EPS $(1.89) Up from $(5.21) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2558499606","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558499606?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:04","pubTimestamp":1754996675,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals (NASDAQ:ACXP) reported Q2 EPS $(1.89) Up from $(5.21) YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47054491/acurx-pharmaceuticals-q2-eps-1-89-up-from-5-21-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP"],"gpt_icon":0},{"id":"2558664998","title":"Acurx Pharmaceuticals, Inc. Reports Second Quarter Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2558664998","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558664998?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:01","pubTimestamp":1754996463,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nTUA2WHW4V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACXP","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2558365911","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2558365911","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558365911?lang=en_us&edition=fundamental","pubTime":"2025-08-11 18:00","pubTimestamp":1754906400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·AMC Ent Hldgs                                    2Q      (.07)  4:15 PM. ·Barrick Mining Corp                                2Q       .46   6:00 AM. ·Gaia Inc. Class A                               2Q      (.08)  4:05 PM. ·Green Plains Inc.                               2Q      (.33)  6:55 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARQ","RAL","ADCT","EE","ARIS","CAE","ALXO","LAR","TLS","MNDY","CAVA","GAIA","HPK","MRVI","GRWG","RUM","DSP","FNV","ASRT","ACXP","INR","CE","EDRY","AIOT","CEVA","IHRT","BKV","ARCT","BHST","CAH","LPSN","COYA","GRDN","BLDP","DDD","MRCY","RNA","AVXL","CAI","PFLT","DEC","BTAI","PAL","BITF","BTM","RPAY","NGS","BW","PNNT"],"gpt_icon":1},{"id":"2557394002","title":"Acurx Pharmaceuticals Inc. Announces Date for Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2557394002","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557394002?lang=en_us&edition=fundamental","pubTime":"2025-08-05 21:19","pubTimestamp":1754399983,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc. has scheduled a special meeting of stockholders for September 16, 2025. The meeting will be held virtually. During the meeting, stockholders will vote on proposals, including one to approve a matter for the purposes of compliance requirements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 04, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDLF85Fp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP","BK4563","BK4539","BK4139"],"gpt_icon":0},{"id":"2555836821","title":"Acurx Pharmaceuticals Announces 1-for-20 Reverse Stock Split Effective August 5, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2555836821","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555836821?lang=en_us&edition=fundamental","pubTime":"2025-07-31 21:25","pubTimestamp":1753968337,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc. announced a 1-for-20 reverse stock split, effective August 4, 2025. The company's common stock will begin trading on a split-adjusted basis on August 5, 2025, under the ticker symbol \"ACXP\" with a new CUSIP number. This move aims to increase the per-share trading price and ensure compliance with Nasdaq's minimum bid price requirement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on July 31, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nNDL7Hvrsc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4539","BK4585","ACXP","LU2095319765.USD","LU2210150020.SGD","IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","BK4139","NDAQ","BK4563","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112"],"gpt_icon":0},{"id":"2555835702","title":"Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2555835702","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555835702?lang=en_us&edition=fundamental","pubTime":"2025-07-31 21:25","pubTimestamp":1753968327,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nTUA2T7Y2D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ACXP","BK4563","BK4139"],"gpt_icon":0},{"id":"2555701835","title":"Acurx Pharmaceuticals Inc - Approves 1-for-20 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2555701835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555701835?lang=en_us&edition=fundamental","pubTime":"2025-07-31 21:25","pubTimestamp":1753968327,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nTUA2T7Y2D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","BK4563","ACXP"],"gpt_icon":0},{"id":"2554931057","title":"Acurx Pharmaceuticals Inc. Announces Date for Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2554931057","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554931057?lang=en_us&edition=fundamental","pubTime":"2025-07-25 22:26","pubTimestamp":1753453609,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals, Inc. is set to hold a special meeting of stockholders on September 16, 2025. The meeting will be conducted virtually via a live audio webcast. One of the key proposals to be voted on during the meeting is to approve matters related to compliance with company requirements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 24, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDL9dbPgV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ACXP","BK4563","BK4139"],"gpt_icon":0},{"id":"2553204022","title":"Acurx Pharmaceuticals Inc. Announces Second Quarter 2025 Financial Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2553204022","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553204022?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:02","pubTimestamp":1753354924,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc. will discuss its second quarter 2025 financial results on Tuesday, August 12, 2025, at 8:00 a.m. ET. The results will be released before the U.S. financial markets open. David P. Luci, President and Chief Executive Officer, and Robert G. Shawah, Chief Financial Officer, will host a conference call. International participants can access the call through participant international Toll-Free access numbers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on July 24, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nNDL3FgFtQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","BK4539","ACXP"],"gpt_icon":0},{"id":"2553204773","title":"Acurx Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 12, 2025 Conference Call and Provide Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2553204773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553204773?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:01","pubTimestamp":1753354865,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nTUA2KL4HZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4139","ACXP","BK4539"],"gpt_icon":0},{"id":"2552431635","title":"Acurx Pharmaceuticals Inc. Conducted Annual Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2552431635","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552431635?lang=en_us&edition=fundamental","pubTime":"2025-07-18 04:07","pubTimestamp":1752782820,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc. held its annual meeting on July 17, 2025. During the meeting, stockholders elected Carl V. Sailer and Thomas Harrison as Class I directors. The appointment of CohnReznick LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. The issuance of shares of common stock underlying Series F Warrants and Wainwright Warrants was approved. The issuance of shares to Lincoln Park Capital Fund, LLC was also approved. An amendment to increase the number of shares available under the 2021 Equity Incentive Plan was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL9ymBW1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4563","ACXP"],"gpt_icon":0},{"id":"2544917042","title":"Acurx Pharmaceuticals Announces $2.67 Million Private Placement Through Warrant Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2544917042","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544917042?lang=en_us&edition=fundamental","pubTime":"2025-06-18 09:47","pubTimestamp":1750211264,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc., a late-stage biopharmaceutical company specializing in developing a new class of antibiotics, has announced a warrant inducement agreement with a holder of existing warrants. This agreement involves the exercise of warrants to purchase up to 4,445,435 shares of common stock at a reduced exercise price of $0.675 per share, generating gross proceeds of approximately $2.67 million. In exchange for this exercise, the investors received G-1 and G-2 warrants to purchase up to 8,890,870 shares of common stock. The G-1 Warrants are immediately exercisable at an exercise price of $0.425 per share, while the G-2 Warrants will become exercisable upon shareholder approval. The company plans to use the net proceeds for working capital and general corporate purposes. The transaction is expected to close by June 20, 2025, pending customary closing conditions.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL7tNPDy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP","BK4563","BK4139","BK4539"],"gpt_icon":0},{"id":"2544399294","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2544399294","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544399294?lang=en_us&edition=fundamental","pubTime":"2025-06-18 02:14","pubTimestamp":1750184079,"startTime":"0","endTime":"0","summary":"CERo Therapeutics  said Tuesday that the US Food and Drug Administration has granted orphan drug designation for its lead drug candidate, CER-1236, for acute myeloid leukemia.Shares jumped over 220% as intraday trading volume advanced to over 51.2 million from a daily average of about 101,000.Acurx Pharmaceuticals  said its lead antibiotic candidate, ibezapolstat, is ready to advance to international phase 3 clinical trials to treat patients with C. difficile infection.Shares soared over 130% as intraday trading volume surged to more than 309 million from a daily average of roughly 182,000.Eli Lilly  said that it agreed to acquire Verve Therapeutics  for up to about $1.3 billion to advance gene-editing therapies for cardiovascular disease.Verve shares soared 78%, with intraday trading volume of more than 72.5 million against a daily average of about 3.49 million.Price: 22.04, Change: +15.18, Percent Change: +220.97","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0417517546.SGD","LU2361045086.USD","SGXZ51526630.SGD","LU0106261372.USD","LU0820561818.USD","BK4588","LU0471298777.SGD","LU1232071149.USD","LU2112291526.USD","LU1366192091.USD","SG9999018857.SGD","BK4516","LU1917777945.USD","LU0097036916.USD","LU0061475181.USD","SGXZ81514606.USD","LU1720051108.HKD","SG9999015945.SGD","CERO","LU1093756168.USD","LU2237443978.SGD","SG9999014906.USD","LU0456855351.SGD","IE00BJT1NW94.SGD","GB00BDT5M118.USD","LU1291159041.SGD","LU1023059063.AUD","LU2468319806.SGD","LU2491050154.USD","LU0889565916.HKD","LU0058720904.USD","LU1974910355.USD","LU0786609619.USD","LU0354030511.USD","BK4007","IE00BK4W5L77.USD","LU2237438978.USD","BK4563","LU0385154629.USD","LU2552382215.SGD","ACXP","IE0009355771.USD","LU0320765992.SGD","SG9999015986.USD","LU2602419157.SGD","LU0320765059.SGD","LU0234572021.USD","LU0354030438.USD"],"gpt_icon":1},{"id":"2544969297","title":"Acurx Pharmaceuticals Announces Promising Phase 2b Clinical Trial Results for Ibezapolstat in Treating C. difficile Infection, Prepares for Phase 3 Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2544969297","media":"Reuters","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544969297?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:01","pubTimestamp":1750158092,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Announces Promising Phase 2b Clinical Trial Results for Ibezapolstat in Treating C. difficile Infection, Prepares for Phase 3 Trials. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on June 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDL7glx6j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4563","ACXP","BK4139"],"gpt_icon":0},{"id":"2542038455","title":"BRIEF-Acurx Pharmaceuticals Announces Presentation Of Results From Leiden University Medical Center Public-Private Partnership For Its DNA pol IIIC Inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2542038455","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542038455?lang=en_us&edition=fundamental","pubTime":"2025-06-09 20:08","pubTimestamp":1749470938,"startTime":"0","endTime":"0","summary":"BRIEF-Acurx Pharmaceuticals Announces Presentation Of Results From Leiden University Medical Center Public-Private Partnership For Its DNA pol IIIC InhibitorsJune 9 (Reuters) - Acurx Pharmaceuticals I","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nTUA2G7MCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4539","ACXP","BK4139"],"gpt_icon":0},{"id":"2542389791","title":"Acurx Pharmaceuticals Announces Advancement of Ibezapolstat to Phase 3 Clinical Trials for C. difficile Infection Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2542389791","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542389791?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:30","pubTimestamp":1749468643,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc. has announced the advancement of its lead antibiotic candidate, ibezapolstat, to international pivotal Phase 3 clinical trials for the treatment of C. difficile infection . The company has been working in collaboration with Leiden University Medical Center  to study the mechanism of action of DNA pol IIIC inhibitors. Results from this collaboration were presented at a scientific conference on May 21 by Dr. Mia Urem from LUMC. These findings provide insight into the structural biology of DNA pol IIIC in complex with inhibitors, which is crucial for developing this new class of antibiotics aimed at treating resistant gram-positive infections. Acurx's Executive Chairman, Bob DeLuccia, emphasized the importance of these data in guiding the design of new compounds to combat antimicrobial resistance. Further details of the presentation are available on the company's website.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL3JvQsf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP","BK4539","BK4563","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":39,"code":"91000000","status":"200"}]}}